A multi-host approach for the systematic analysis of virulence factors in cryptococcus neoformans

Journal of Infectious Diseases

Volumn 211, Issue 2, 2015, Pages 298-305

  Desalermos, Athanasios ^a,b   Tan, Xiaojiang ^a,d   Rajamuthiah, Rajmohan ^a   Arvanitis, Marios ^a   Wang, Yan ^a,c   Li, Dedong ^a,d   Kourkoumpetis, Themistoklis K ^a,b   Fuchs, Beth Burgwyn ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Caenorhabditis elegans; Cryptococcus neoformans; Galleria mellonella; model host; pathogenesis; virulence

Indexed keywords

VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAENORHABDITIS ELEGANS; CKS101 GENE; CNA2580 GENE; CNC5600 GENE; CND1850 GENE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CSN1201 GENE; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS IDENTIFICATION; GALLERIA MELLONELLA; GENE FUNCTION; GENE IDENTIFICATION; HAP502 GENE; HOST PATHOGEN INTERACTION; MLH3 GENE; MOUSE; MSL5 GENE; MURINE MODEL; NONHUMAN; PATHOGENESIS; RDI1 GENE; SRE1 GENE; WILD TYPE; YLR243W GENE; YOL003C GENE; ANIMAL; DISEASE MODEL; GENE DELETION; GENETIC SCREENING; GENETICS; MICROBIOLOGY; MOTH; PATHOGENICITY; PATHOLOGY;

ANIMALS; CAENORHABDITIS ELEGANS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; FEMALE; GENE DELETION; GENETIC TESTING; MICE; MOTHS; VIRULENCE FACTORS;

EID: 84922553479     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu441     Document Type: Article

References (47)

1. Desalemos A, Kourkoumpetis T, Mylonakis E. Update on the epidemiology and management of cryptococcal meningitis. Expert Opin Pharmacother 2012; 13:783-9.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-30.
3. SabiitiW, May RC, Pursall ER. Experimental models of cryptococcosis. Int J Microbiol 2012; 2012:626745.
4. Desalermos A, Fuchs BB, Mylonakis E. Selecting an invertebrate model host for the study of fungal pathogenesis. PLoS Pathog 2012; 8: e1002451.
5. Lee IR, Yang L, Sebetso G, et al. Characterization of the complete uric acid degradation pathway in the fungal pathogen Cryptococcus neoformans. PLoS One 2013; 8:e64292.
6. Morrow CA, Valkov E, Stamp A, et al. De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans. PLoS Pathog 2012; 8:e1002957.
7. Lee IR, Lim JW, Ormerod KL, Morrow CA, Fraser JA. Characterization of an Nmr homolog that modulates GATA factor-mediated nitrogen metabolite repression in Cryptococcus neoformans. PLoS One 2012; 7: e32585.
8. Mylonakis E, Ausubel FM, Perfect JR, Heitman J, Calderwood SB. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc Natl Acad Sci U S A 2002; 99:15675-80.
9. Tang RJ, Breger J, Idnurm A, et al. Cryptococcus neoformans gene involved in mammalian pathogenesis identified by a Caenorhabditis elegans progeny-based approach. Infect Immun 2005; 73:8219-25.
10. Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-50.
11. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 2008; 135:174-88.
12. Nielsen K, Cox GM, Wang P, Toffaletti DL, Perfect JR, Heitman J. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates. Infect Immun 2003; 71:4831-41.
13. Idnurm A, Reedy JL, Nussbaum JC, Heitman J. Cryptococcus neoformans virulence gene discovery through insertional mutagenesis. Eukaryot Cell 2004; 3:420-9.
14. Tan MW, Mahajan-Miklos S, Ausubel FM. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc Natl Acad Sci U S A 1999; 96:715-20.
15. Beanan MJ, Strome S. Characterization of a germ-line proliferation mutation in C. elegans. Development 1992; 116:755-66.
16. Tanaka-Hino M, Sagasti A, Hisamoto N, et al. SEK-1 MAPKK mediates Ca2+ signaling to determine neuronal asymmetric development in Caenorhabditis elegans. EMBO Rep 2002; 3:56-62.
17. Tampakakis E, Okoli I, Mylonakis E. A C. elegans-based, whole animal, in vivo screen for the identification of antifungal compounds. Nat Protoc 2008; 3:1925-31.
18. Fuchs BB, O'Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475-82.
19. Eisenman HC, Chow SK, Tse KK, McClelland EE, Casadevall A. The effect of L-DOPA on Cryptococcus neoformans growth and gene expression. Virulence 2011; 2:329-36.
20. Ram AF, Klis FM. Identification of fungal cell wall mutants using susceptibility assays based on Calcofluor white and Congo red. Nat Protoc 2006; 1:2253-6.
21. Fuchs BB, Tegos GP, Hamblin MR, Mylonakis E. Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother 2007; 51: 2929-36.
22. Mylonakis E, Idnurm A, Moreno R, et al. Cryptococcus neoformans Kin1 protein kinase homologue, identified through a Caenorhabditis elegans screen, promotes virulence in mammals. Mol Microbiol 2004; 54:407-19.
23. Arvanitis M, Glavis-Bloom J, Mylonakis E. Invertebrate models of fungal infection. Biochim Biophys Acta 2013; 1832:1378-83.
24. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, Mylonakis E. Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 2007; 3:e18.
25. Desalermos A, Muhammed M, Glavis-Bloom J, Mylonakis E. Using C. elegans for antimicrobial drug discovery. Expert Opin Drug Discov 2011; 6:645-52.
26. Rajamuthiah R, Fuchs BB, Jayamani E, et al. Whole Animal Automated Platform for Drug Discovery against Multi-Drug Resistant Staphylococcus aureus. PLoS One 2014; 9:e89189.
27. Mylonakis E. Galleria mellonella and the study of fungal pathogenesis: making the case for another genetically tractable model host. Mycopathologia 2008; 165:1-3.
28. Garcia-Solache MA, Izquierdo-Garcia D, Smith C, Bergman A, Casadevall A. Fungal virulence in a lepidopteran model is an emergent property with deterministic features. MBio 2013; 4:e00100-13.
29. Garcia-Rodas R, Casadevall A, Rodriguez-Tudela JL, Cuenca-Estrella MZaragoza O. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 2011; 6: e24485.
30. Garsin DA, Sifri CD, Mylonakis E, et al. A simple model host for identifying Gram-positive virulence factors. Proc Natl Acad Sci U S A 2001; 98:10892-7.
31. Chang YC, Bien CM, Lee H, Espenshade PJ, Kwon-Chung KJ. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol Microbiol 2007; 64:614-29.
32. Price MS, Nichols CB, Alspaugh JA. The Cryptococcus neoformans Rho-GDP dissociation inhibitor mediates intracellular survival and virulence. Infect Immun 2008; 76:5729-37.
33. Alonso B, Beraud C, Meguellati S, et al. Eukaryotic GPN-loop GTPases paralogs use a dimeric assembly reminiscent of archeal GPN. Cell Cycle 2013; 12:463-72.
34. Lam KK, Davey M, Sun B, Roth AF, Davis NG, Conibear E. Palmitoylation by the DHHC protein Pfa4 regulates the ER exit of Chs3. J Cell Biol 2006; 174:19-25.
35. Sacristan C, Manzano-Lopez J, Reyes A, Spang A, Muniz M, Roncero C. Oligomerization of the chitin synthase Chs3 is monitored at the Golgi and affects its endocytic recycling. Mol Microbiol 2013; 90:252-66.
36. Fuchs BB, Mylonakis E. Our paths might cross: the role of the fungal cell wall integrity pathway in stress response and cross talk with other stress response pathways. Eukaryot Cell 2009; 8:1616-25.
37. Bolotin A, Wincker P, Mauger S, et al. The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res 2001; 11:731-53.
38. Flores-Rozas H, Kolodner RD. The Saccharomyces cerevisiae MLH3 gene functions in MSH3-dependent suppression of frameshift mutations. Proc Natl Acad Sci U S A 1998; 95:12404-9.
39. Goffeau A, Barrell BG, Bussey H, et al. Life with 6000 genes. Science 1996; 274:546, 563-7.
40. Hadwiger JA, Wittenberg C, Mendenhall MD, Reed SI. The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex. Mol Cell Biol 1989; 9:2034-41.
41. Hortschansky P, Eisendle M, Al-Abdallah Q, et al. Interaction of HapX with the CCAAT-binding complex-A novel mechanism of gene regulation by iron. EMBO J 2007; 26:3157-68.
42. Jung WH, Saikia S, Hu G, et al. HapX positively and negatively regulates the transcriptional response to iron deprivation in Cryptococcus neoformans. PLoS Pathog 2010; 6:e1001209.
43. Nishant KT, Plys AJ, Alani E. A mutation in the putative MLH3 endonuclease domain confers a defect in both mismatch repair and meiosis in Saccharomyces cerevisiae. Genetics 2008; 179:747-55.
44. Schwer B, Chang J, Shuman S. Structure-function analysis of the 5' end of yeast U1 snRNA highlights genetic interactions with the Msl5.∗Mud2 branchpoint-binding complex and other spliceosome assembly factors. Nucleic Acids Res 2013; 41:7485-500.
45. Chang J, Schwer B, Shuman S. Structure-function analysis and genetic interactions of the yeast branchpoint binding protein Msl5. Nucleic Acids Res 2012; 40:4539-52.
46. Eisenman HC, Mues M, Weber SE, et al. Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA. Microbiology 2007; 153:3954-62.
47. Nosanchuk JD, Casadevall A. The contribution of melanin to microbial pathogenesis. Cell Microbiol 2003; 5:203-23.